Molecular mechanisms of vascular permeability in diabetic retinopathy.

Diabetes leads to a wide array of complications in humans, including kidney failure, vascular disease, peripheral nerve degeneration, and vision loss. Diabetic retinopathy causes blindness in more working-age people in the United States than any other disease and contributes greatly to blindness in the young and old as well. The increasing rate of diabetes occurring in our society can only bring about a further decrease in the visual health of this country unless new modalities are discovered to prevent and cure diabetic retinopathy. Breakdown of the blood-retinal barrier and the resultant vascular permeability remains one of the first observable alterations in diabetic retinopathy and strongly correlates with vision loss. In this article, we examine the molecular components that form this blood-retinal barrier and explore how changes in the production of growth factors in the neural parenchyma cause an increase in vascular permeability and contribute to retinal degeneration.

[1]  J. Cunha-Vaz,et al.  Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. , 1966, The British journal of ophthalmology.

[2]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[3]  D. Paul,et al.  COOH Terminus of Occludin Is Required for Tight Junction Barrier Function in Early Xenopus Embryos , 1997, The Journal of cell biology.

[4]  A. Barber,et al.  Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. , 1998, Diabetes.

[5]  J. Tarbell,et al.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.

[6]  C. Michel,et al.  Openings Through Endothelial Cells Associated with Increased Microvascular Permeability , 1999, Microcirculation.

[7]  Thomas S. Reese,et al.  FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.

[8]  K. Nakagawa,et al.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[9]  P Massin,et al.  Growth factors and diabetic retinopathy. , 1997, Diabetes & metabolism.

[10]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[11]  D. McDonald,et al.  Endothelial Gaps as Sites for Plasma Leakage in Inflammation , 1999, Microcirculation.

[12]  V. J. Venema,et al.  VEGF-induced permeability increase is mediated by caveolae. , 1999, Investigative ophthalmology & visual science.

[13]  J. Tarbell,et al.  Physiological transport properties of cultured retinal microvascular endothelial cell monolayers. , 1997, Current eye research.

[14]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.

[15]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[16]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[17]  L. Gu,et al.  ZO-3, a Novel Member of the MAGUK Protein Family Found at the Tight Junction, Interacts with ZO-1 and Occludin , 1998, The Journal of cell biology.

[18]  L. Rubin,et al.  A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.

[19]  S. Citi,et al.  Tight junction proteins. , 1998, Biochimica et biophysica acta.

[20]  Hidehiro Ishii,et al.  Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.

[21]  P. Campochiaro,et al.  Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. , 1995, Experimental eye research.

[22]  T. Gardner,et al.  Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1 , 1999, The Journal of Biological Chemistry.

[23]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[24]  C. V. Van Itallie,et al.  Tight junctions and the molecular basis for regulation of paracellular permeability. , 1995, The American journal of physiology.

[25]  K. Fujimoto,et al.  Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Dvorak,et al.  Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea‐fig, mouse and rat: many are transcellular pores , 1997, The Journal of physiology.

[27]  H. Dvorak,et al.  Pathways of Macromolecular Extravasation Across Microvascular Endothelium in Response to VPF/VEGF and Other Vasoactive Mediators , 1999, Microcirculation.

[28]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[29]  C. Zucker,et al.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.

[30]  M. Itoh,et al.  Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues , 1996, The Journal of cell biology.

[31]  James M. Anderson,et al.  Molecular architecture of tight junctions. , 1998, Annual review of physiology.

[32]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[33]  G. Lutty,et al.  Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.

[34]  M. Itoh,et al.  Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions , 1994, The Journal of cell biology.

[35]  B. Keon,et al.  The tight junction: morphology to molecules. , 1998, Annual review of cell and developmental biology.

[36]  C. V. Van Itallie,et al.  Occludin confers adhesiveness when expressed in fibroblasts. , 1997, Journal of cell science.

[37]  C. Kevil,et al.  Expression of Zonula Occludens and Adherens Junctional Proteins in Human Venous and Arterial Endothelian Cells: Role of Occludin in Endothelial Solute Barriers , 1998, Microcirculation.

[38]  R. D. Lynch,et al.  Occludin is a functional component of the tight junction. , 1996, Journal of cell science.

[39]  H. Hammes,et al.  Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. , 1998, Diabetes.

[40]  S. Nigam,et al.  Molecular structure and assembly of the tight junction. , 1998, American journal of physiology. Renal physiology.

[41]  G. Palade,et al.  JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA , 1963, The Journal of cell biology.

[42]  M. Itoh,et al.  Involvement of ZO-1 in Cadherin-based Cell Adhesion through Its Direct Binding to α Catenin and Actin Filaments , 1997, The Journal of cell biology.

[43]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[44]  S. Tsukita,et al.  Effects of tyrosine phosphorylation on tight junctions in temperature-sensitive v-src-transfected MDCK cells. , 1995, Cell structure and function.

[45]  J. Scott,et al.  Organization of kinases, phosphatases, and receptor signaling complexes. , 1999, The Journal of clinical investigation.

[46]  Ivana K. Kim,et al.  Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.

[47]  R. Lifton,et al.  Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. , 1999, Science.

[48]  J. Cunha-Vaz,et al.  Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. , 1998, Experimental eye research.

[49]  J. Spranger,et al.  Growth Factor Alterations in Advanced Diabetic Retinopathy: A Possible Role of Blood Retina Barrier Breakdown , 1997, Diabetes.

[50]  James M. Anderson,et al.  The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin Cytoskeleton* , 1998, The Journal of Biological Chemistry.

[51]  L. Aiello,et al.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.

[52]  J. W. Miller Vascular endothelial growth factor and ocular neovascularization. , 1997, The American journal of pathology.

[53]  M. Cooper,et al.  Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[54]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[55]  M. Balda,et al.  Occludin and the functions of tight junctions. , 1999, International review of cytology.

[56]  J. Cunha-Vaz,et al.  Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. , 1966, Experimental eye research.

[57]  J. Alexander,et al.  Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.

[58]  A. Barber,et al.  Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.

[59]  T. Noda,et al.  Occludin-deficient Embryonic Stem Cells Can Differentiate into Polarized Epithelial Cells Bearing Tight Junctions , 1998, The Journal of cell biology.

[60]  A. Patz,et al.  Clinically significant macular edema in type I diabetes. Incidence and risk factors. , 1995, Ophthalmology.

[61]  C. V. Van Itallie,et al.  Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. , 1995, Journal of cell science.

[62]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[63]  B. Giepmans,et al.  The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein , 1998, Current Biology.

[64]  P. Campochiaro,et al.  Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes , 1997, The British journal of ophthalmology.

[65]  C. V. Van Itallie,et al.  Zonula occludens (ZO)-1 and ZO-2: membrane-associated guanylate kinase homologues (MAGuKs) of the tight junction. , 1995, Biochemical Society transactions.

[66]  J. Robertson,et al.  Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. , 1994, Investigative ophthalmology & visual science.

[67]  Harold E. Dvorak,et al.  Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin , 1996, The Journal of experimental medicine.

[68]  L. Rubin,et al.  Evidence that tyrosine phosphorylation may increase tight junction permeability. , 1995, Journal of cell science.

[69]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[70]  L. Aiello Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. , 1998, Ophthalmic research.